Xiao Yan Qin
Chief Tech/Sci/R&D Officer at Zensun (Shanghai) Sci & Tech Co., Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ming Dong Zhou | M | 69 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 24 years |
Ting Fang Cao | F | 46 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 22 years |
Peng Fei Xu | M | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 years |
Xiu Hua Zhang | F | 49 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 22 years |
Xiao Long Zhang | M | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 years |
Zheng Gang Jiang | M | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 16 years |
Ting Dai | F | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 19 years |
Yi Wei | M | 75 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 years |
Zhe Wang | M | 35 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 6 years |
Jin Juan Shi | F | 48 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 years |
Wei Hu Fan | M | 80 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 years |
Jian Mei Gan | F | 64 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 years |
Wen Hong Jin | M | 74 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 11 years |
Ming De Fan | M | 48 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 years |
Kun Yang | M | 49 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 years |
Fu Yun Guo | F | 42 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 5 years |
Yan Jin | F | 46 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 9 years |
Xiao Long Liu | M | 67 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 9 years |
Bin Xi | M | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 23 years |
Chen Zhu Ge | M | 45 |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 8 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Xi Fu Liu | M | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 17 years |
Xin Yan Li | M | - |
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | 16 years |
Statistics
Country | Connections | % of total |
---|---|---|
China | 22 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Xiao Yan Qin
- Personal Network